Potential of Sodium-Glucose Cotransporter-2 Inhibitors in the Management of Heart Failure With Preserved Ejection Fraction: A Narrative Review
2024

SGLT2 Inhibitors for Heart Failure Management

Sample size: 5900 publication 10 minutes Evidence: high

Author Information

Author(s): Muacevic Alexander, Adler John R, Alsuwayh Abdulaziz F, Altawili Mohammed, Alhazmi Marwan Fahad, Alotaibi Dhuha Faisal M, Rashed Alghamdi Omar, Obaid Abdullah Alharbi Hussam, Alkenani Ahad Ahmad N, Almohammdi Rudayna adel S, Alotaibi Hamad Fahad M, Fatima Essamaldin Altahir Mohamed Alsharif

Hypothesis

Can sodium-glucose cotransporter-2 inhibitors improve outcomes in heart failure with preserved ejection fraction?

Conclusion

SGLT2 inhibitors significantly reduce heart failure hospitalizations and improve cardiovascular outcomes in patients with heart failure with preserved ejection fraction.

Supporting Evidence

  • SGLT2 inhibitors significantly reduce heart failure hospitalizations.
  • These medications improve cardiovascular mortality rates.
  • Patients with chronic kidney disease benefit from SGLT2 inhibitors.
  • SGLT2 inhibitors enhance health-related quality of life in elderly patients.
  • Clinical guidelines recommend SGLT2 inhibitors for heart failure management.

Takeaway

SGLT2 inhibitors help people with heart failure feel better and stay out of the hospital.

Methodology

A comprehensive literature search identified randomized controlled trials, meta-analyses, and clinical studies evaluating SGLT2 inhibitors in managing heart failure with preserved ejection fraction.

Limitations

Further research is needed to refine patient-specific strategies and explore additional benefits.

Participant Demographics

The review includes various populations, including diabetic patients, the elderly, and those with chronic kidney disease.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI: 4.8-10.9

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.7759/cureus.73906

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication